During the last session, Ernexa Therapeutics Inc (NASDAQ:ERNA)’s traded shares were 88849.0, with the beta value of the company hitting 5.53. At the end of the trading day, the stock’s price was $0.19, reflecting an intraday gain of 0.65% or $0.01. The 52-week high for the ERNA share is $2.62, that puts it down -1278.95 from that peak though still a striking 21.05% gain since the share price plummeted to a 52-week low of $0.15. The company’s market capitalization is $11.50M, and the average intraday trading volume over the past 10 days was 0.18 million shares, and the average trade volume was 637.43K shares over the past three months.

Ernexa Therapeutics Inc (NASDAQ:ERNA) trade information

Ernexa Therapeutics Inc (ERNA) registered a 0.65% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 0.65% in intraday trading to $0.19, hitting a weekly high. The stock’s 5-day price performance is -0.64%, and it has moved by -33.19% in 30 days. Based on these gigs, the overall price performance for the year is -91.44%. The short interest in Ernexa Therapeutics Inc (NASDAQ:ERNA) is 0.21 million shares and it means that shorts have 1.06 day(s) to cover.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 35.26%.

ERNA Dividends

Ernexa Therapeutics Inc is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Ernexa Therapeutics Inc (NASDAQ:ERNA)’s Major holders

Ernexa Therapeutics Inc insiders own 69.03% of total outstanding shares while institutional holders control 1.60%, with the float percentage being 5.16%.

Also, the Mutual Funds coming in first place with the largest holdings of Ernexa Therapeutics Inc (ERNA) shares are Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund . Data provided on Feb 28, 2025 indicates that Fidelity Concord Street Trust-Fidelity Extended Market Index Fund owns about 209.56 shares. This amounts to just over 0.34 percent of the company’s overall shares, with a $38768.0 market value. The same data shows that the other fund manager holds slightly less at 41.02, or about 0.07% of the stock, which is worth about $7587.0.